Effects of insulin and transferrin on the generation of lymphokine-activated killer cells in serum-free medium

Journal of Immunological Methods

Volumn 195, Issue 1-2, 1996, Pages 7-14

  Okamoto, Tetsuji ^a   Tani, Ryouji ^a   Yabumoto, Masahumi ^a   Sakamoto, Akihiko ^a   Takada, Kazuaki ^a   Sato, Gordon H ^b   Sato, J Denry ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Adirondack Biomedical Research Institute Inc   (United States)

Author keywords

Adoptive immunotherapy; Head and neck cancer; Lymphokine activated killer cell; Serum free culture

Indexed keywords

ETHANOLAMINE; INSULIN; INTERLEUKIN 2; MERCAPTOETHANOL; RECOMBINANT INTERLEUKIN 2; SODIUM SELENITE; TRANSFERRIN;

ADULT; ARTICLE; CANCER IMMUNOTHERAPY; CULTURE MEDIUM; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOKINE ACTIVATED KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030576908     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-1759(96)00081-6     Document Type: Article

References (35)

1. Atsumi, T., Miwa, Y., Kimata, K. and Ikawa, Y. (1990) A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ. Dev. 30, 109.
2. Barnes, D. and Sato, G.H. (1980) Serum-free cell culture: a unifying approach. Cell 22, 649.
3. Barre-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, C., Vezinet-Brun, F., Rouzioux, C., Rosenbaum, W. and Montagnier, L. (1983) Isolation of a T lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868.
4. Beckner, S.K. and Longo, D.L. (1987) Media for LAK cell generation. Cancer Treat. Rep. 71, 104.
5. Brown, R.L., Ortaldo, J.R., Griffith, R.L., Blanca, I. and Rabin, H. (1985) The proliferation and function of human mononuclear leukocytes and natural killer cells in serum-free medium. J. Immunol. Methods 81, 207.
6. Choo, Q., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W. and Houghson, M. (1989) Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359.
7. Cullen, K.J., Yee, D., Sly, W.S., Perdue, J., Hampton, B., Lippman, M.E. and Rosen, N. (1990) Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res. 50, 48.
8. Dane, D.S., Cameron, C.H. and Briggs, M. (1970) Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 695.
9. Fabricant, R.N., DeLarco, J.E. and Todaro, G.J. (1977) Nerve growth factor receptors on human melanoma cells in culture. Proc. Natl. Acad. Sci. USA 74, 565.
10. Froelich, C.J. and Guiffaut, S. (1986) Induction of lymphokine activated killer cells in serum-free medium. J. Immunol. Methods 86, 205.
11. Furue, M., Okamoto, T., Ikeda, M., Tanaka, Y., Sasaki, Y., Nishihara, K and Sato, J.D. (1994) Primitive neuroectodermal tumor cell lines derived from a metastatic pediatric tumor. In Vitro Cell. Dev. Biol. 30A, 813.
12. Goding, J.W. and Burns, G.F. (1981) Monoclonal antibody OKT-9 recognizes the receptor for transferrin on human acute lymphocytic leukemia cells. J. Immunol. 127, 1256.
13. Grimm, E.A., Mazumder, A., Zhang, H.Z. and Rosenberg, S.A. (1982) Lymphokine-activated killer cell phenomenon lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autolougous human peripheral blood lymphocytes. J. Exp. Med. 155, 1823.
14. Itoh, K., Tilden, A.B. and Balch, C.M. (1985) Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells. Cancer Res. 45, 3173.
15. Kato, K., Yamada, T., Kawahara, K., Onoda, H., Asano, T., Sugino, H. and Kakinuma, A. (1985) Purification and characterization of recombiant human interleukin-2 produced in Escherichia coli. Biochem. Biophys. Res. Commun. 130, 692.
16. Kawamoto, T., Sato, J.D., Le, A., McClure, D.B. and Sato, G.H. (1983) Development of a serum-free medium for growth of NS-1 mouse myeloma cells and its application of NS-1 hybridomas. Anal. Biochem. 130, 445.
17. Kemp, J.D., Thorson, J.A., Gomez, F., Smith, K.M., Cowdery, J.S. and Ballas, Z.K. (1989) Inhibition of lymphocyte activation with anti-transferrin receptor mabs: a comparison of three reagents and further studies of their range of effects and mechanism of action. Cell. Immunol. 122, 218.
18. Lozzio, C.B. and Lozzio, B.B. (1975) Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45, 321.
19. Macaulay, V.M., Everard, M.J., Teale, J.D., Trott, P.A., Van Wyk, J.J., Smith, I.E. and Millar, J.L. (1990) Autocrine function for insulin-like growth factor 1 in human small cell lung cancer cell lines and fresh tumor cells. Cancer Res. 50, 2511.
20. Miyauchi, S., Moroyama, T., Kyoizumi, S., Asakawa, J., Okamoto, T. and Takada, K. (1988) Malignant tumor cell lines produce intereukin-1-like factor. In Vitro Cell. Dev. Biol. 24, 753.
21. Muul, L.M., Director, E.P., Hyatt, C.L. and Rosenberg, S.A. (1986) Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapy. J. Immunol. Methods 88, 265.
22. Muul, L.M., Nason-Burchenal, K., Hyatt, C., Schwarz, S., Slavin, D., Director, E.P. and Rosenberg, S.A. (1987) Studies of serum-free culture medium in the generation of lymphokine activated killer cells. J. Immunol. Methods 105, 183.
23. Myoken, Y., Okamoto, T., Osaki, T., Yabumoto, M., Sato, G.H., Takada, K. and Sato, J.D. (1989) An alternative method for the isolation of NS-1 hybridomas using cholesterol auxotrophy of NS-1 mouse myeloma cells. In Vitro Cell. Dev. Biol. 25, 477.
24. Myoken, Y., Kayada, Y., Okamoto, T., Kan, M., Sato, G.H. and Sato, J.D. (1991) Vascular endothelial cell growth factor(VEGF) produced by A431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc. Natl. Acad. Sci. USA 88, 5819.
25. Myoken, Y., Myoken, Y., Okamoto, T., Sato, J.D. and Takada, K. (1994) Immunocytochemical localization of fibroblast growth factor-1 and FGF-2 in oral squamous cell carcinoma. J. Oral Pathol. Med. 23, 451.
26. Myoken, Y., Myoken Y., Okamoto, T., Sato, J.D. and Takada, K. (1995) Effect of fibroblast growth factor-1 on the three dimensional growth and morphogenesis of human salivary gland epithelial cells embedded in collagen gels. In Vitro Cell. Dev. Biol. 31, 84.
27. Naruo, K., Hinuma, S., Kato, K., Koyama, M., Tada, H., Shiho, O. and Tsukamoto, K. (1985) Comparison of the biological properties of purified natural and recombinant human interleukin-2. Biochem. Biophys. Res. Commun. 128, 257.
28. Pulbertaft, R.J.V. and Cantab, M.D. (1964) Cytology of Burkitt's tumour (African lymphoma). Lancet 1, 238.
29. Rosenberg, S.A., Lotze, M.T., Muul, L.M., Leitman, S., Chang, A.E., Ettinghausen, S.E., Matory, Y.L., Skibber, J.M.,. Shiloni, E., Vetto, J.T., Seipp, C.A., Simpson, C. and Reichert, C.M. (1985) Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. New Engl. J. Med. 313, 1485.
30. Rosenberg, S.A., Lotze, M.T., Muul, L.M., Chang, A.E., Avis, F.P., Leitman, S., Linehan, W.M., Robertson, C.N., Lee, R.E., Rubin, J.T., Seipp, C.A., Simpson, C.G. and White, D.E. (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukine-2 or high-dose interleukin-2 alone. New Engl. J. Med. 316, 889.
31. Sanderson, A.R. (1964) Applications of isoimmune cytolysis using radiolabelled target cells. Nature 204, 250.
32. Sato, J.D., Kawamoto, T. and Okamoto, T. (1987) Cholesterol requirement of P3-X63-Ag8 and X63-Ag8.653 mouse myeloma cells for growth in vitro. J. Exp. Med. 165, 1761.
33. Serrero, G. (1985) Tumorigenicity associated with loss of differentiation and of response to insulin in the adipogenic cell line 1246. In Vitro Cell. Dev. Biol. 21, 537.
34. Wu, D., Kan, M., Sato, G.H., Okamoto, T. and Sato, J.D. (1991) Characterization and molecular cloning of a putative binding protein for heparin-binding growth factor. J. Biol. Chem. 266, 16778.
35. Yssel, H., De Vries, J.E., Koken, M., Blitterswijk, W.V. and Spits, H. (1984) Serum-free medium for the generation and propagation of funtional human cytotoxic and helper T cell clones. J. Immunol. Methods 72, 219.